Related Experiment Video
Updated: Aug 9, 2025

Studying the Role of Alveolar Macrophages in Breast Cancer Metastasis
Published on: June 26, 2016
Macrophages and bone metastasis
Diletta Di Mitri1,2, Fabio Conforti3, Alberto Mantovani4,5
1Department of Biomedical Sciences, Humanitas University , Pieve Emanuele, Italy.
Abstract:
In the prostate bone metastasis microenvironment, macrophages activate a cascade that involves Activin A, the extracellular matrix, and SRC kinase and drives resistance to anti-androgen therapy. These findings (Li et al., 2023. J. Exp. Med.https://doi.org/10.1084/jem.20221007) have broad implications, including metastasis diversity in different tissue milieus and the interplay between hormones and immunity.
Insights
Macrophages in prostate cancer bone metastasis create a pathway involving Activin A, extracellular matrix, and SRC kinase. This cascade drives resistance to anti-androgen therapy, impacting hormone and immunity interactions.
Area of Science:
- Oncology
- Immunology
- Cell Biology
Background:
- Prostate cancer bone metastasis is a complex microenvironment.
- Therapy resistance is a major clinical challenge in advanced prostate cancer.
- The interplay between the immune system and cancer cells is crucial for tumor progression.
Purpose of the Study:
- To elucidate the molecular mechanisms driving resistance to anti-androgen therapy in prostate bone metastasis.
- To identify key cellular and molecular players within the bone metastasis microenvironment.
Main Methods:
- Investigated the role of macrophages in the prostate bone metastasis microenvironment.
- Analyzed the signaling cascade involving Activin A, extracellular matrix, and SRC kinase.
- Assessed the impact of this cascade on anti-androgen therapy resistance.
Main Results:
- Macrophages activate a cascade involving Activin A, extracellular matrix, and SRC kinase.
- This cascade promotes resistance to anti-androgen therapy in prostate cancer bone metastasis.
- Findings highlight the heterogeneity of metastasis in different tissue environments.
Conclusions:
- The identified pathway is a critical driver of treatment resistance in prostate cancer bone metastasis.
- Understanding this interplay between hormones and immunity offers new therapeutic targets.
- Metastasis diversity is influenced by tissue-specific microenvironmental factors.
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Osteoclasts in Bone Remodeling

